Money Concepts Capital Corp Novartis Ag Transaction History

Money Concepts Capital Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$80.03 - $92.81 $195,193 - $226,363	-2,439 Reduced 17.75%	11,304 $1.04 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $112,191 - $137,392	1,485 Added 12.11%	13,743 $1.25 Million
Q3 2022 Oct 27, 2022	BUY	$74.61 - $87.26 $845,629 - $989,004	11,334 Added 1226.62%	12,258 $932,000
Q2 2022 Jul 18, 2022	SELL	$80.52 - $93.75 $167,562 - $195,093	-2,081 Reduced 69.25%	924 $78,000
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $240,730 - $272,313	3,005 New	3,005 $264,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Money Concepts Capital Corp with notifications on news.